FDA Approved: MAVYRET — Original Application (AbbVie Inc.)

View source ↗

Summary

FDA approved MAVYRET (glecaprevir and pibrentasvir) from AbbVie in an Original Application for the treatment of hepatitis C virus infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Mavyret (glecaprevir/pibrentasvir)

Snippet

ORIG AP for MAVYRET (GLECAPREVIR AND PIBRENTASVIR)